Towards a therapeutic window of D2/3 occupancy for treatment of psychosis in Alzheimer's disease, with [18F]fallypride positron emission tomography

Establishing Test–Retest Reliability of an Adapted [18F]Fallypride Imaging Protocol in Older People

(2013) Joel T Dunn et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Therapeutic Window for Striatal Dopamine D2/3 Receptor Occupancy in Older Patients With Schizophrenia

(2012) Hiroyuki Uchida et al.   AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY

Origins of delusions in Alzheimer's disease

(2012) Suzanne J. Reeves et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

The applicability of SRTM in [18F]fallypride PET investigations: Impact of scan durations

(2011) Ingo Vernaleken et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Imaging dopamine receptors in humans with [11C]-(+)-PHNO: Dissection of D3 signal and anatomy

(2010) Andri C. Tziortzi et al.   NEUROIMAGE

Amisulpride - dose, plasma concentration, occupancy and response: implications for therapeutic drug monitoring

(2009) A. Sparshatt et al.   ACTA PSYCHIATRICA SCANDINAVICA

Sensitivity of Older Patients to Antipsychotic Motor Side Effects: A PET Study Examining Potential Mechanisms

(2009) Hiroyuki Uchida et al.   AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY

Increased Antipsychotic Sensitivity in Elderly Patients

(2009) Hiroyuki Uchida et al.   JOURNAL OF CLINICAL PSYCHIATRY

No effect of donepezil on striatal dopamine release in mild to moderate Alzheimer's disease

(2009) S Reeves et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Increased striatal dopamine (D2/D3) receptor availability and delusions in Alzheimer disease

(2009) S. Reeves et al.   NEUROLOGY

Striatal and Extrastriatal D2/D3-Receptor-Binding Properties of Ziprasidone

(2008) Ingo Vernaleken et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Dose–Occupancy Study of Striatal and Extrastriatal Dopamine D2 Receptors by Aripiprazole in Schizophrenia with PET and [18F]Fallypride

(2008) Lawrence S Kegeles et al.   NEUROPSYCHOPHARMACOLOGY

Striatal D2/D3 Receptor Occupancy, Clinical Response and Side Effects with Amisulpride: An Iodine-123-Iodobenzamide SPET Study

(2008) E. Meisenzahl et al.   PHARMACOPSYCHIATRY

Cortical Dopamine D2/D3 Receptors Are a Common Site of Action for Antipsychotic Drugs--An Original Patient Data Meta-analysis of the SPECT and PET In Vivo Receptor Imaging Literature

(2008) J. M. Stone et al.   SCHIZOPHRENIA BULLETIN

Small effect of dopamine release and no effect of dopamine depletion on [18F]fallypride binding in healthy humans

(2008) Vanessa L. Cropley et al.   SYNAPSE